Saranya Sridhar Asia-Pacific Vaccine and Immunotherapy Congress 2023

Saranya Sridhar

Saranya Sridhar is the Head of Translational Medicine at Sanofi Vaccines and Global Head for COVID-19 and mRNA Vaccines Clinical Franchise. In this role, he leads the clinical development program of Sanofi’s COVID-19 vaccine. As Head of Translational Medicine, his team’s focus is on translational clinical research and early development on optimizing the mRNA vaccine technology and understanding the mechanism of action of mRNA vaccines. He has led approval of COVID-19 vaccine, dengue vaccine and in early development on next-generation influenza vaccines. His expertise is in translational research and clinical development with particular interest in respiratory pathogens. He earned his medical degree in India and then was awarded a Rhodes Scholarship to pursue a D.Phil at the University of Oxford where he worked on developing adenoviral vectored vaccines for malaria and tuberculosis. He completed a Masters in Epidemiology as a Fogarty International HIV Training Fellowship from University of California at Berkeley. He joined Sanofi after fellowships at Imperial College London and the Jenner Institute, Oxford where he worked on T-cell correlates of protection and T-cell focused vaccines against influenza and tuberculosis.